Correlation Between Phathom Pharmaceuticals and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Phathom Pharmaceuticals and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phathom Pharmaceuticals and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phathom Pharmaceuticals and Nuvectis Pharma, you can compare the effects of market volatilities on Phathom Pharmaceuticals and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phathom Pharmaceuticals with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phathom Pharmaceuticals and Nuvectis Pharma.
Diversification Opportunities for Phathom Pharmaceuticals and Nuvectis Pharma
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Phathom and Nuvectis is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Phathom Pharmaceuticals and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Phathom Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phathom Pharmaceuticals are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Phathom Pharmaceuticals i.e., Phathom Pharmaceuticals and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Phathom Pharmaceuticals and Nuvectis Pharma
Given the investment horizon of 90 days Phathom Pharmaceuticals is expected to generate 0.96 times more return on investment than Nuvectis Pharma. However, Phathom Pharmaceuticals is 1.04 times less risky than Nuvectis Pharma. It trades about 0.03 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about 0.01 per unit of risk. If you would invest 879.00 in Phathom Pharmaceuticals on September 7, 2024 and sell it today you would earn a total of 21.00 from holding Phathom Pharmaceuticals or generate 2.39% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Phathom Pharmaceuticals vs. Nuvectis Pharma
Performance |
Timeline |
Phathom Pharmaceuticals |
Nuvectis Pharma |
Phathom Pharmaceuticals and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Phathom Pharmaceuticals and Nuvectis Pharma
The main advantage of trading using opposite Phathom Pharmaceuticals and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phathom Pharmaceuticals position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.The idea behind Phathom Pharmaceuticals and Nuvectis Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |